Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yikon Genomics has developed and commercialized proprietary single-cell whole-genome amplification technologies licensed from Harvard University. Their products are clinically validated and widely used in reproductive genetics and personalized cancer diagnostics across hundreds of medical institutions globally[1][4]. The company’s NICS/niPGT-A test was among the first non-invasive preimplantation genetic tests approved in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yikon Genomics.